Analysts expect that MedAvail Holdings, Inc. (NASDAQ:MDVL – Get Rating) will announce earnings of ($0.36) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for MedAvail’s earnings. MedAvail reported earnings per share of ($0.29) during the same quarter last year, which indicates a negative year over year growth rate of 24.1%. The company is expected to report its next quarterly earnings results on Monday, January 1st.
According to Zacks, analysts expect that MedAvail will report full-year earnings of ($0.80) per share for the current year. For the next fiscal year, analysts anticipate that the company will post earnings of ($0.54) per share. Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that that provide coverage for MedAvail.
MedAvail (NASDAQ:MDVL – Get Rating) last released its quarterly earnings results on Thursday, March 24th. The company reported ($0.38) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.04). MedAvail had a negative return on equity of 121.31% and a negative net margin of 198.00%. During the same period in the previous year, the company posted ($0.57) EPS.
In other news, major shareholder Wtt-Medavail Ltd Abg bought 14,117,646 shares of MedAvail stock in a transaction that occurred on Monday, April 4th. The shares were purchased at an average price of $1.06 per share, for a total transaction of $14,964,704.76. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 3.70% of the stock is currently owned by company insiders.
Several institutional investors and hedge funds have recently modified their holdings of MDVL. Morgan Stanley acquired a new position in shares of MedAvail during the first quarter worth about $63,000. Parametric Portfolio Associates LLC purchased a new stake in shares of MedAvail during the second quarter worth about $177,000. Deutsche Bank AG increased its position in shares of MedAvail by 1,239.6% during the third quarter. Deutsche Bank AG now owns 93,206 shares of the company’s stock worth $272,000 after acquiring an additional 86,248 shares during the last quarter. Russell Investments Group Ltd. purchased a new stake in shares of MedAvail during the third quarter worth about $805,000. Finally, State Board of Administration of Florida Retirement System purchased a new stake in shares of MedAvail during the third quarter worth about $74,000. Institutional investors own 80.86% of the company’s stock.
MedAvail stock traded up $1.00 during mid-day trading on Friday, hitting $2.44. 54,821,162 shares of the company were exchanged, compared to its average volume of 17,996,246. The company has a debt-to-equity ratio of 0.50, a current ratio of 3.65 and a quick ratio of 3.13. The business’s 50 day simple moving average is $1.19 and its two-hundred day simple moving average is $1.69. The company has a market capitalization of $80.30 million, a P/E ratio of -1.83 and a beta of 0.96. MedAvail has a 12-month low of $0.79 and a 12-month high of $14.59.
MedAvail Company Profile (Get Rating)
MedAvail Holdings, Inc, a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada. It operates in two segments, Retail Pharmacy Services and Pharmacy Technology.
- Get a free copy of the StockNews.com research report on MedAvail (MDVL)
- Institutions And Analysts Drive UnitedHealth Group Higher
- MarketBeat: Week in Review 4/11 – 4/15
- Three Beaten Down Mega Caps The Analysts Are Upgrading
- Top 3 Safe Stocks for Conservative Investors
- UiPath Stock is Nearing Rock Bottom Down Here
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MedAvail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedAvail and related companies with MarketBeat.com's FREE daily email newsletter.